Trials including mostly patients with other diagnoses, suchas aging-associated memory impairment or mild cognitiveimpairment, and trials using EGb 761 as add-on treatmentto cholinesterase inhibitors, were excluded. This evidence concerns the gene BCHE and memory impairment.